Zealand Pharma

Director's Dealing • May 12, 2023

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Adam Steensberg
2.	Reason for the notification
a)	Position/status	Chief Executive Officer
b)	Initial notification/Amend ment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc tion monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI1	549300ITBB1ULBL4CZ12
4.		Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Performance Stock Units Description of the financial instrument, type of instru ment
	Identification code	DK0060257814
b)	Nature of the transaction	Vesting and allocation of Performance Stock Units
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 257.6	17,372
d)	Aggregated information - Aggregated volume - Price	17,372 DKK 4,475,027.2
e)	Date of the transaction	May 12, 2023
f)	Place of the transaction	Outside trading venue